Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine and Paroxetine in Bipolar Depression
NCT00119652Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by AstraZeneca. Started May 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00119652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119652.